The trimethoxyamphetamines (TMA) are a family of designer drugs developed on an amphetamine base. TMA-6, known more formally as 2,4,6-trimethoxyamphetamine, is a psychedelic hallucinogen which has appeared on the illicit drug market. Unlike amphetamines and cathinones, TMA-6 has no effect on the release or re-uptake of monoamines (dopamine, serotonin, and norepinephrine). This product is intended for research and forensic applications.
2,4,6-Trimethoxyamphetamine is a psychedelic hallucinogen drug and a substituted amphetamine that has no effects on the release or re-uptake of monoamines.
